This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Other. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 317 
1 out of 834,659 Years Active: 2022-2026
Title: The Innovative Mind of Annika Kraemer-Kuehl
Introduction
Annika Kraemer-Kuehl, an accomplished inventor based in Seesen, Germany, has made significant contributions to the field of veterinary medicine through her innovative research. With a total of six patents to her name, she has focused her work on identifying and developing novel immunogenic compositions, particularly in relation to avian coronaviruses.
Latest Patents
Among her latest patents, Kraemer-Kuehl's work includes the development of an attenuated Infectious Bronchitis Virus (IBV) with extended cell culture and tissue tropism. This invention pertains to an IBV that has been deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16. The invention also encompasses any descendant IBV and any form of IBV that exhibits all identifying characteristics of the deposited strain. Furthermore, Kraemer-Kuehl has developed a modified S1 subunit of the coronavirus spike protein, which involves a recombinant avian coronavirus spike protein or a fragment containing a mutation at amino acid position 267 to Cysteine. This modification is foundational for creating an immunogenic composition comprising an avian coronavirus with the altered spike protein.
Career Highlights
Throughout her career, Annika has been associated with Boehringer Ingelheim Vetmedica GmbH, where she has contributed her expertise in developing groundbreaking veterinary solutions. Her work has been pivotal in understanding and combating infectious diseases that affect poultry, thereby enhancing global food security.
Collaborations
Kraemer-Kuehl has collaborated with notable professionals in her field, including Hans-Christian Philipp and Thomas Min Stephan. These collaborations have fostered an environment of innovation and have led to significant advancements in the research and development of veterinary vaccines and immunogenic compositions.
Conclusion
Annika Kraemer-Kuehl stands out as a leading figure in veterinary medicine innovation. Her significant contributions, as evidenced by her patents and collaborations, continue to shape the landscape of research in avian diseases. As the field evolves, her work will undoubtedly remain integral in fostering healthier animal populations around the globe.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile